期刊文献+

IGF-1R的真核表达和单克隆抗体的制备 被引量:2

下载PDF
导出
摘要 目的:IGF-1R稳定表达株的建立和抗IGF-1R单克隆抗体(mAb)的制备。方法:从cDNA扩增得到人全长IGF-1R基因,构建成含有E-Tag的质粒。用此质粒建立稳定表达IGF-1R的细胞株,并免疫BALB/c小鼠,经融合、筛选制备特异性mAb。结果:成功构建IGF-1R病毒质粒,并筛选得到稳定表达IGF-1R的3T3细胞,该细胞免疫BALB/c小鼠后筛选得到6株稳定分泌抗IGF-1R抗体的杂交瘤细胞株,Western blot结果显示抗体8G3能特异性识别抗原。结论:成功制备了IGF-1R的mAb,为进一步研究IGF-1R在肿瘤治疗中的作用提供了有力的工具。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第12期1192-1193,共2页 Chinese Journal of Cellular and Molecular Immunology
基金 上海市科委重大项目资助(06DZ19501)
  • 相关文献

参考文献9

  • 1Russell WE, Van Wyk JJ, Pledger WJ, et al. Inhibition of the mitogenic effect of plasma by a monoclonal antibody to somatomedin C [ J ]. Proc Natl Acad Sci USA, 1984, 81(8) : 2389 -2393.
  • 2Rubini M, Hongo A, Dambrosio C, et al. The IGF-1 receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number[J]. Exp Cell Res, 1997, 230(2) : 284 -292.
  • 3Valentinis B, Baserga R. IGF-I receptor signaling in transformation and differentiation[ J]. Mol Pathol, 2001, 54 (3) : 133 - 137.
  • 4Hellawell GO, Turner GD, Davies DR, et al. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease[ J]. Cancer Res, 2002, 62( 10): 2942-2950.
  • 5余抒,罗萍,陈洪章,李海侠,毛旭虎.抗肠出血性大肠杆菌O157:H7 EspA单克隆抗体的制备及其特性鉴定[J].细胞与分子免疫学杂志,2007,23(7):657-659. 被引量:5
  • 6Lllmans EE, Roelen AJ, Damme HS, et al. Assessmenl of the functional affinity constant of monoclonal antibodies using an improved enzyme-linked immunosorbent assay[ J ]. Immunol Methods, 1995, 184 (2) : 207 -217.
  • 7Karas M, Danilenko M, Fishnan D, et al. Membrane associated insulin-like growth factor binding protein 3 inhibits insulin-like growth factor-I induced insulin like growth factor-I receptor signaling in Ishikawa endometrial cancer cells[J]. Biol Chem, 1997, 272(26) : 16514 - 16520.
  • 8Kathrin J, Scheidegger, Bruno Cenni, et al. Estradiol decreases IGF-1 and IGF-1 receptor expression in rat aortic smooth muscle cells [ J ]. Biol Chem, 2000, 275(49) : 38921 -38928.
  • 9Sepp-Lorenzino L. Structure and function of the insulin-like growth factor I receptor[ J ]. Breast Cancer Res Treat, 1998, 47 (3) : 235 - 253.

二级参考文献12

  • 1白慧玲,赵粤萍,刘广超,马远方.非竞争ELISA法测定抗DR5单克隆抗体功能性亲和常数[J].河南大学学报(医学版),2005,24(4):11-13. 被引量:7
  • 2张君,张娟,唐霓,张秉强,陈维贤,黄爱龙,郑建.抗O139群霍乱弧菌单克隆抗体的制备和生物学特性的鉴定[J].细胞与分子免疫学杂志,2006,22(3):374-376. 被引量:8
  • 3王庆旭,毛旭虎,邹全明,曾韦锟,罗萍,程建平,易勇,马颖.肠出血性大肠埃希菌O157:H7 espA基因的克隆与表达[J].中华微生物学和免疫学杂志,2006,26(6):535-538. 被引量:7
  • 4司徒镇强 吴军正.细胞培养[M].西安:世界图书版出版公司,2004.78-202.
  • 5汪家政 范明.蛋白质技术手册[M].北京:科学出版社,2002.77-97.
  • 6Frankel G,Phillips AD,Rosenshine I,et al.Enteropathogenic and enterohaemorrhagicEscherichia coli:more subversive elements[J].Mol Microbiol,1998,30(5):911-921.
  • 7周志江.肠出血性大肠杆菌O157[M].北京:军事医学科学出版社,2002:82-84.
  • 8Garmendia J,Frankel G.Enteropathogenic and EnterohemorrhagicEscherichia coli Infections:Translocation,Translocation,Translocation[J].Infect Immun,2005,73(5):2573-2585.
  • 9Crepin1 VF,Shaw R.Molecular basis of antigenic polymorphism of EspA filaments:development of a peptide display technology[J].J Mol Biol,2005,350(1):42-52.
  • 10Brent R,Ausubel F 著(颜子颖,王海林,译).精编分子生物学实验指导[M].北京:科学出版社,1999,366-373.

共引文献4

同被引文献22

  • 1Seung Oe Lim,Sung Gyoo Park,Jun-Hi Yoo,Young Min Park,Hie-Joon Kim,Kee-Taek Jang,Jae Won Cho,Byung Chul Yoo,Gu-Hung Jung,Cheol Keun Park.Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules[J].World Journal of Gastroenterology,2005,11(14):2072-2079. 被引量:62
  • 2O' Connor R, Fennelly C, Krause D. Regulation of survival sig- nals from the insulin-like growth factor- I receptor [J]. Biochem Soc Trans, 2000, 28(2) : 47-51.
  • 3Tennant MK, Thrasher JB, Twomey PA, et al. Insulin-like growth factor-binding protein-2 and -3 expression in benign human pros- tate epithelium, prostate intraepithelial neoplasia, and adenoearci- noma of the prostate [J]. J Clin Endocrinol Metab, 1996, 81 (1): 411-420.
  • 4Wang Y, Sun Y. Insulin-like growth factor receptor- I as an anti-cancer target: Blocking transformation and inducing apoptosis [J]. Curr Cancer Drug Targets, 2002, 2(3) : 191-207.
  • 5Tovar V, Alsinet C, Villanueva A, et al. IGF activation in a mo- lecular subclass of hepatocellular carcinoma and pre-clinical effica- cy of IGF-I R blockage [J]. J Hepatol, 2010, 52 (4): 550- 559.
  • 6Slomiany MG , Black LA , Kibbey MM, et al. Insulin-like growth factor- I receptor and ligand targeting in head and neck squamous cell carcinoma [J]. Cancer Lett, 2007, 248(2) : 269-279.
  • 7Gest C, Mirshahi P, Li H, et al. Ovarian cancer: Stat3, RhoA and IGF- I R as therapeutic targets [J]. Cancer Lett, 2012, 317 (2) : 207-217.
  • 8Kalli KR, Conover CA. The insulin-like growth factor/insulin sys- tem in epithelial ovarian cancer [ J]. Front Biosci, 2003 ( 1 ), 8 : d714-d722.
  • 9Lu Y, Zi X, Zhao Y, et al. Insulin-like growth factor- I receptor signaling and resistance to trastuzumab (Herceptin) [ J ]. J Natl Cancer Inst, 2001, 93(24) : 1852-1857.
  • 10Qian X, Yu J, Yin Y, et al. MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers [J]. Cell Cycle, 2013, 12(9) :1385-1394.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部